Hyperfine (NASDAQ:HYPR) Shares Up 1.5% – Here’s Why

Hyperfine, Inc. (NASDAQ:HYPR) was up 1.5% during mid-day trading on Thursday . The stock traded as high as $1.02 and last traded at $1.01. Approximately 62,037 shares were traded during mid-day trading, a decline of 38% from the average daily volume of 100,791 shares. The stock had previously closed at $1.00.

Hyperfine Price Performance

The stock has a market cap of $72.95 million, a P/E ratio of -1.75 and a beta of 0.86. The firm’s 50 day moving average price is $0.97 and its 200-day moving average price is $1.00.

Hyperfine (NASDAQ:HYPR) last released its quarterly earnings data on Tuesday, November 12th. The company reported ($0.14) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.14). The business had revenue of $3.64 million for the quarter, compared to analysts’ expectations of $3.40 million. Hyperfine had a negative return on equity of 57.54% and a negative net margin of 309.42%. During the same period in the prior year, the firm posted ($0.15) EPS. On average, analysts expect that Hyperfine, Inc. will post -0.57 earnings per share for the current year.

Institutional Investors Weigh In On Hyperfine

An institutional investor recently raised its position in Hyperfine stock. Geode Capital Management LLC raised its stake in shares of Hyperfine, Inc. (NASDAQ:HYPR) by 18.7% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 624,520 shares of the company’s stock after acquiring an additional 98,335 shares during the period. Geode Capital Management LLC owned approximately 0.86% of Hyperfine worth $675,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 15.03% of the company’s stock.

Hyperfine Company Profile

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.